LeafNLP Demos
Back to explore

Report #2877315

Received Dec 10, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
67 yrs
State
VA
Recovered
Unknown
Vaccinated
Oct 9, 2023
Onset
—
Days to onset
—
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH13342056-4250OT / LA
FLU3INFLUENZA (SEASONAL) (FLUZONE)SANOFI PASTEUR13342057-4250—
RSVRSV (ABRYSVO)PFIZER\WYETH13342059-4250—

Symptoms (1)

Psoriasis

Symptom narrative

he developed plaque psoriasis afterwards; This is a spontaneous report received from an Other HCP and a Consumer or other non HCP, Program ID. A 67-year-old male patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 09Oct2023 as dose 1, single (Lot number: 3342056-4250) at the age of 67 years intramuscular, in left arm for covid-19 immunisation; rsv vaccine prot.subunit pref 2v (ABRYSVO), on 09Oct2023 as dose 1, single (Lot number: 3342059-4250) at the age of 67 years, in arm for immunisation; influenza vaccine inact split 3v (FLUZONE SENIOR), on 09Oct2023 as dose 1, single (Lot number: 3342057-4250), in arm for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, single; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 2, single; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 3, single; unknown manufacturer), for COVID-19 immunization. The following information was reported: PSORIASIS (non-serious), outcome "unknown", described as "he developed plaque psoriasis afterwards". Additional information: it was reported that the patient was administered all 3 vaccines (Abrysvo, Comirnaty, Fluzone HF65+) in the same time, and he developed plaque psoriasis afterwards.